About Us
- Overview
  We advance the field of genomic science by leveraging our key strengths.
- Our People
  Each individual brings unique expertise to the NYGC’s team of innovators.
- Contact Us
  Contact us with general inquiries or for more information.
  - NYGC Team Login
Science & Technology
- Collaborative Research Programs
  We work with leading medical and academic institutions in New York and beyond.
- Faculty Labs
  Dive into the profiles of our faculty members and learn about their research.
- Technology Platforms
  Our advanced technology platforms provide essential tools for researchers.
Collaborate with Us
- Affiliate Membership Program
  The NYGC currently has 95 Affiliate Members, representing 18 academic institutions and medical centers.
- Scientific Collaboration & Project Management
  The Project Management team works across disciplines and institutions with partners in academia, industry, private foundations, and large consortia to bring the promise of genomics to bear on biomedical research.
  - Research Administration
  - Research Sequencing
- Tech Transfer
  Our dedicated technology transfer personnel identify research results with potential commercial interest.
Publications
Careers
- Our Culture & Values
  The NYGC’s core values of collaboration, innovation, integrity, and community engagement are reflected in all aspects of our work.
  - Diversity, Equity & Inclusion
  - Benefits
- Open Positions & Training Opportunities
  Join us on our mission to advance genomic science and its application to novel biomedical discoveries.
  - Post-Baccalaureate Program
  - Internship Program
News & Events
- News
  Access press releases, research updates, and feature articles.
  - Press Room
- Events
  Discover exciting events, including seminars, workshops, webinars, and conferences.
  - Past Events

About Us > Our People > Board of Directors > Anthony B. Evnin, PhD

Anthony B. Evnin, PhD

Board Member, NYGC Former Partner, Venrock

Anthony (Tony) B. Evnin joined Venrock in 1974 and built the firm’s healthcare franchise, helping to shape the modern biotechnology industry until his retirement in 2021. He serves as a member of the Boards of Overseers and Managers of Memorial Sloan Kettering Cancer Center; as a Trustee Emeritus of The Rockefeller University, Princeton University, and The Jackson Laboratory; as a director of the New York Genome Center; and as a member of the Board of Directors of the Lasker Foundation and chair of its Board since 2018. Evnin received his AB in Chemistry from Princeton University and his PhD in chemistry from the Massachusetts Institute of Technology.